ArticleIndian journal of psychiatry2026
Clinical practice guideline for assessment and management of depression in India.
Article in Indian journal of psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07633080 (Efficacy and Safety of Add-on Magnesium Bisglycinate in Major Depressive Disorder), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Efficacy and Safety of Add-on Magnesium Bisglycinate in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial
Who cites it
1 citing paper in PubMed.
- Integrated management of dry eye-depression comorbidity: mechanistic insights and temporal therapeutic strategies.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This Clinical Practice Guideline has aimed to provide mental health practitioners a comprehensive and evidence-based framework that can be used for the assessment and management of depression specifically catered to the Indian population. Considering the high prevalence of depression and its burden on the affected persons as well as the medical system, these guidelines were needed to help provide psychiatric care that matches the international standards and the cultural and practical needs of the Indian population. The article outlies key risk factors, components of assessment, and pharmacological and psychological management, along with structured approaches for suicide risk management. It also seeks to outline recommended investigations, differential diagnosis, and clinical decision guidelines based on the severity of the psychopathology. Guidelines are offered for the selection of antidepressants, treatment phases, monitoring, switching or augmenting strategies, and tapering the pharmacological treatment. Management strategies for comorbidities, special populations, and treatment-resistant depression are offered in this article. Newer treatment modalities including neuromodulation and novel pharmacological agents showing promise are discussed. Overall, the guideline aims to support clinicians in delivering personalized, effective, and culturally appropriate care for individuals with depression in India.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.